Contact

Representative before the EPO

Employment test 11 - 50 employees
Company dna gill jennings and every llp
operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

Fiona Stevens has worked on the following 46 EPO patent applications which have been published in the last five years:

EP11716018

ELECTROCHEMICAL CELL STACK

IPC classification:
H01M 8/24
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP10856512

USE OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID AND RELATED COMPOUNDS FOR PREVENTION AND/OR TREATMENT OF PULMONARY FIBROSIS

IPC classification:
A61K 31/16, A61K 31/19, A61K 31/215, A61K 31/22, A61K 31/221, A61K 31/235, A61K 31/661, A61K 31/70, A61K 31/704, A61P 11/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP12720944

USE OF BETHANECHOL FOR TREATMENT OF XEROSTOMIA

IPC classification:
A61K 9/00, A61K 31/27, A61K 31/37, A61P 43/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12726847

HIGH WATER-CONTENT MEMBRANES

IPC classification:
H01M 8/10
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP12807955

NUCLEIC ACID COMPLEX

IPC classification:
A61K 47/30, A61K 47/48, A61K 48/00, C08F 287/00, C08F 293/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP12868721

SYSTEM AND METHOD FOR DISPOSAL OF MUTAGEN WASTE

IPC classification:
A47K 11/10, E03D 9/10
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP13755158

METHOD FOR PREPARING EMULSION RESIN COMPOSITION FOR CATIONIC ELECTRODEPOSITION COATING

IPC classification:
C09D 5/02, C09D 5/44, C09D 163/00, C09D 175/04
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
PATENT GRANTED
EP12772374

EFFERVESCENT CLEANING COMPOSITION COMPRISING DIAMOND POWDER HAVING DV50 OF LESS THAN 40MICROMETER

IPC classification:
B28D 7/02, C11D 3/00, C11D 13/14, C11D 17/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
PATENT GRANTED
EP12780263

BIOSORBABLE ENDOPROSTHESIS

IPC classification:
A61L 31/00, A61L 31/02, A61L 31/08, A61L 31/14, A61L 31/18
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP12848275

SENSOR INTERFACE SYSTEM

IPC classification:
A61B 8/02
Agent:
Finnegan Europe LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP13188131

A composition for treatment of advanced prostate cancer

IPC classification:
A61K 38/19, A61K 38/20, A61K 38/21, A61K 45/00, A61P 37/04
Agent:
Hedley William Austin, Chapman + Co
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP10836605

METHOD OF REVERSING IMMUNE SUPPRESSION OF LANGERHANS CELLS

IPC classification:
C12P 21/04
Agent:
Hedley William Austin, Chapman + Co
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13159961

Alpha 5 - beta 1 antibodies and their uses

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Pfizer Inc
Applicant:
Bristol-Myers Squibb Company
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13170322

Lithium-sulfur battery with performance enhanced additives

IPC classification:
H01M 4/38, H01M 4/58, H01M 10/052, H01M 10/0567
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14173186

Use of amisulpride for treating opioid-induced nausea and vomiting

IPC classification:
A61K 9/00, A61K 31/282, A61K 31/40, A61K 31/4178, A61K 31/485, A61K 33/24, A61K 45/06, A61K 47/12, A61P 1/08
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13703121

1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61K 31/496, A61P 35/00, A61P 37/00, C07D 471/04
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
PATENT GRANTED
EP13708227

SEWAGE SCREENING SYSTEM

IPC classification:
B01D 33/04, E02B 8/02
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13709523

PHOSPHOINOSITIDE 3-KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 25/00, C07D 413/14
Applicant:
Karus Therapeutics Limited
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP12797537

VEGETABLE OIL EXTRACTION

IPC classification:
A23L 1/025, A23L 3/30, B01D 11/04, C11B 1/10, C11B 3/00, C11B 3/16
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
PATENT GRANTED
EP14189232

Advantageous Salts of MU-Opiate Receptor Peptides

IPC classification:
A61K 38/07, A61P 1/00, A61P 25/30, A61P 29/00, C07K 5/107
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13717777

DEVICE FOR REMOVING AN ITEM IMPLANTED UNDERNEATH THE SKIN

IPC classification:
A61B 17/30, A61B 17/50, A61F 6/06, A61M 5/42
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP11755105

THEOBROMINE IN COMBINATION WITH AN EXPECTORANT OR A MUCOLYTIC FOR USE IN THERAPY

IPC classification:
A61K 31/047, A61K 31/085, A61K 31/09, A61K 31/122, A61K 31/137, A61K 31/185, A61K 31/197, A61K 31/198, A61K 31/223, A61K 31/235, A61K 31/265, A61K 31/357, A61P 11/10, A61P 11/12, A61P 11/14
Agent:
George Schlich, Schlich LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP10796123

THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE

IPC classification:
A61K 31/4402, A61K 31/522, A61K 45/06, A61P 11/14
Agent:
George Schlich, Schlich LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP10795446

COMBINATION OF THEOBROMINE WITH A DECONGESTANT AND ITS USE FOR THE TREATMENT OF COUGH

IPC classification:
A61K 31/137, A61K 31/522, A61P 11/14
Agent:
George Schlich, Schlich LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP14194820

The therapeutic use of tetrathiomolybdate

IPC classification:
A61K 33/24, A61P 9/10, A61P 13/12
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14191564

Binding molecules to the human OX40 receptor

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
Pfizer Inc
Applicant:
Bristol-Myers Squibb Company
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
PATENT GRANTED
EP11743126

GRADUATED COMPRESSION HOSIERY

IPC classification:
A41B 11/00, A61F 13/06, A61F 13/08
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
APPLICATION WITHDRAWN
EP12188047

Use of amisulpride for treating chemotherapy-induced nausea and vomiting

IPC classification:
A61K 9/00, A61K 31/282, A61K 31/40, A61K 31/4178, A61K 31/485, A61K 47/12, A61P 1/08
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13831735

RIFLE MOUNTED PEPPER SPRAY DEVICE WITH SLIDE ACTIVATION

IPC classification:
F41B 11/81, F41B 15/00, F41C 7/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
APPLICATION WITHDRAWN
EP13771745

MATERIALS AND METHODS FOR PROTECTING AGAINST NEUROMAS

IPC classification:
A61L 31/04
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13840746

ANASTOMOSIS CLIPPING TOOL WITH HALF-LOOP CLIP

IPC classification:
A61B 17/03
Applicant:
Children's National Medical Center
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP11702694

TREATMENT OF RESPIRATORY DISORDERS

IPC classification:
A61K 31/192, A61K 47/14, A61K 47/44
Agent:
George Schlich, Schlich LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
APPLICATION WITHDRAWN
EP13792060

NOVEL HISTONE DEACETYLASE INHIBITORS AND THEIR USE IN THERAPY

IPC classification:
A61K 31/4439, A61P 7/00, A61P 9/00, A61P 29/00, A61P 35/00, C07D 401/12
Applicant:
Karus Therapeutics Limited
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP12195976

Method of producing binding molecules for the human OX40 receptor

IPC classification:
C07K 16/28
Applicant:
Pfizer Inc
Applicant:
Bristol-Myers Squibb Company
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14737892

DECELLULARIZED BIOMATERIAL FORM NON-MAMMALIAN TISSUE

IPC classification:
A61F 2/00, A61K 9/10, A61K 9/14, A61K 35/56, A61L 27/36
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
GRANT OF PATENT INTENDED
EP14701599

ANATOMICALLY TARGETED COMPRESSION CLOTHING

IPC classification:
A41D 13/00, A41D 13/005, A61F 7/02, A61F 13/08, A61F 13/10, A61F 13/14
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP14765332

SILANE CONTAINING COATINGS

IPC classification:
C09D 5/08, C23C 22/00, C23F 11/12
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION REQUESTED
EP14714310

JEWELLERY CLEANING WIPE

IPC classification:
C11D 3/14, C11D 3/20, C11D 17/04
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION REQUESTED
EP14717821

THE TREATMENT OF INFLAMMATORY DISORDERS

IPC classification:
A61K 31/4375, A61K 31/47, A61K 31/4709, A61K 31/473, A61K 31/4741, A61K 31/5025, A61K 31/519, A61K 45/06, A61P 11/00, A61P 11/06, A61P 17/00, A61P 17/06, A61P 19/02, A61P 19/10, A61P 29/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION REQUESTED
EP14717820

THE LOCAL TREATMENT OF INFLAMMATORY OPHTHALMIC DISEASES

IPC classification:
A61K 9/00, A61K 31/4375, A61K 31/47, A61K 31/4709, A61K 31/473, A61K 31/4741, A61K 31/5025, A61K 31/519, A61K 45/06, A61P 27/02, A61P 29/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
EXAMINATION REQUESTED
EP12189630

Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the heart

IPC classification:
A61K 33/24, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11716626

TETRATHIOMOLYBDATE FOR USE IN THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY OF THE HEAD OR BRAIN

IPC classification:
A61K 33/24, A61P 7/04, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707639

PRESSURE SENSOR

IPC classification:
A61F 13/00
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11711126

A WEARABLE GARMENT AND ITS USE IN PREVENTING STRETCH MARKS

IPC classification:
A41C 1/10, A61F 5/03
Applicant:
UCL Business plc
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11719612

NAPHTHRIDINE DERIVATIVES AS PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNE-INFLAMMATORY DISEASES

IPC classification:
A61K 31/4375, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Karus Therapeutics Limited
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11784752

INFLAMMATORY DISEASE

IPC classification:
A61K 9/00, A61K 9/06, A61K 31/00
Agent:
George Schlich, Schlich LLP
Agent:
Fiona Stevens, Gill Jennings & Every LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature